Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RecycLiCo Battery Materials Inc. V.AMY

Alternate Symbol(s):  AMYZF

RecycLiCo Battery Materials Inc is a critical metals company focused on the recycling of lithium-ion batteries with the RecycLiCo Patented Process. The process provides high extraction of cathode metals, such as lithium, cobalt, nickel, manganese, and aluminium at battery-grade purity, with minimal processing steps. It aims to commercialize its breakthrough RecycLiCo Patented Process and become an industry leader in recycling cathode materials from spent lithium-ion batteries.


TSXV:AMY - Post by User

Post by geraldson Oct 22, 2021 2:34pm
147 Views
Post# 34038485

News release

News release

News Release - October 22, 2021

 

American Manganese Appoints Director

 

October 22, 2021 - Surrey, B.C. Canada

TSX-V: AMY | OTCQB: AMYZF | FSE: 2AM

American Manganese Inc. ("AMY" or the "Company"),is pleased to announce that Dr. Paul Hildebrand, LlB., PhD., has been appointed a director of the Company. Dr. Hildebrand has been a practicing lawyer in British Columbia for over 40 years and has a doctorate in economics in addition to his law degree and Master of Science degree in mathematics. He was previously a director of AMY from 2007 to 2013.

The Company’s board of directors has granted Dr. Hildebrand 400,000 stock options with an exercise price of $0.80 per share and expiring five years from today.

Larry Reaugh, CEO says Dr. Hildebrand has proven his abilities especially in the field of litigation and is a welcome addition to the Company. 


<< Previous
Bullboard Posts
Next >>